Valuation Thiogenesis Therapeutics, Corp.

Stocks

Market Closed - Toronto S.E. 20:45:01 01/10/2026 BST			5-day change	1st Jan Change
0.4900 ^CAD	0.00%		-5.77%	-24.62%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	22.54	33.43	27.61	33.69
Change	-	48.3%	-17.4%	22.03%
Enterprise Value (EV) ¹	16.34	26.35	23.76	32.08
Change	-	61.23%	-9.83%	34.99%
P/E	-3.74x	-5.8x	-8.65x	-4.25x
PBR	3.77x	6.04x	8.06x	58.7x
PEG	-0x	0.3x	0.2x	-0x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	-8.14x	-5.06x	-6.64x	-4.34x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ³	-	-	-	-
Rate of return	-	-	-	-
EPS ³	-0.1552	-0.1294	-0.0693	-0.1528
Distribution rate	-	-	-	-
Net sales	-	-	-	-
EBITDA	-	-	-	-
EBIT ¹	-2.009	-5.206	-3.579	-7.395
Net income ¹	-3.924	-5.063	-3.146	-7.426
Net Debt ¹	-6.196	-7.076	-3.848	-1.616
Reference price ³	0.5800	0.7500	0.6000	0.6500
Nbr of stocks (in thousands)	38,862	44,571	46,017	51,836
Announcement Date	28/04/23	29/04/24	25/04/25	30/04/26

¹CAD in Million²USD in Million³CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
THIOGENESIS THERAPEUTICS, CORP.	-	-	-	-	24.05M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	20.98x	31.37x	12.47x	0.31%	39.06B
Weighted average by Cap.	22.27x	32.04x	13.55x	0.42%